Immunoassay-Compatible Inactivation of SARS-CoV-2 in Plasma Samples for Enhanced Handling Safety-Reference-Cited by-同舟云学术

Immunoassay-Compatible Inactivation of SARS-CoV-2 in Plasma Samples for Enhanced Handling Safety

Published:2022-07-14 Issue:29 Volume:7 Page:25510-25520
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Liew Oi Wah¹^ORCID,Fanusi Felic²³,Ng Jessica Yan Xia¹,Ahidjo Bintou Ahmadou²³,Ling Samantha Shi Min¹,Lilyanna Shera¹,Chong Jenny Pek Ching¹,Lim Angeline Eng Siew¹,Lim Wei Zheng¹,Ravindran Sindhu²,Chu Justin Jang Hann²³⁴^ORCID,Lim Shir Lynn⁵⁶,Richards Arthur Mark¹⁷

Affiliation:

1. Cardiovascular Research Institute, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, National University Health System, 14 Medical Drive, Singapore 117599, Singapore

2. NUS Medicine BSL3 Core Facility, Yong Loo Lin School of Medicine, National University of Singapore, National University Health System, 14 Medical Drive, Singapore 117599, Singapore

3. Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, 5 Science Drive 2, Singapore 117545, Singapore

4. Infectious Disease Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore

5. Yong Loo Lin School of Medicine, National University of Singapore, National University Health System, 1E Kent Ridge Road, Singapore 119228, Singapore

6. Department of Cardiology, National University Heart Centre Singapore, 1E Kent Ridge Road, Singapore 119228, Singapore

7. Christchurch Heart Institute, University of Otago, Christchurch 8140, New Zealand

Funder

National University of Singapore

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.2c02585

Reference38 articles.

1. SARS-CoV-2: air/aerosols and surfaces in laboratory and clinical settings

2. Safety considerations in the bioanalytical laboratories handling specimens from coronavirus disease 2019 patients

3. Interim Laboratory Safety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19). https://www.cdc.gov/coronavirus/2019-ncov/lab/lab-biosafety-guidelines.html (Accessed May 1, 2021).

4. Ten scientific reasons in support of airborne transmission of SARS-CoV-2

5. Covid-19 has redefined airborne transmission

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sandwich ELISA for the Quantification of Nucleocapsid Protein of SARS-CoV-2 Based on Polyclonal Antibodies from Two Different Species;International Journal of Molecular Sciences;2023-12-26

2. Advancing diagnostic efficacy using a computer vision-assisted lateral flow assay for influenza and SARS-CoV-2 detection;The Analyst;2023

3. Validation of Viral Inactivation Protocols for Therapeutic Blood Products against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2);Viruses;2022-10-31